Growth in the 340B Drug Pricing Program
Link
Additional link
Description
Explores trends in drug purchases through the 340B program between 2010-2021. Discusses drugs purchased through the Prime Vendor Program, factors contributing to growth in the 340B program, and effects of the 340B program on the federal budget. Includes information on the growth of 340B Program participation by hospitals in Medicaid expansion and non-expansion states by Critical Access Hospital designation.
Date
09/2025
Organization
Congressional Budget Office
Tagged as
Healthcare business and finance
· Healthcare facilities
· Pharmacy and prescription drugs
· Policy
· Statistics and data